M.F. El Etreby

1.7k total citations
75 papers, 1.3k citations indexed

About

M.F. El Etreby is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Reproductive Medicine. According to data from OpenAlex, M.F. El Etreby has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Genetics and 16 papers in Reproductive Medicine. Recurrent topics in M.F. El Etreby's work include Estrogen and related hormone effects (23 papers), Hormonal and reproductive studies (20 papers) and Growth Hormone and Insulin-like Growth Factors (16 papers). M.F. El Etreby is often cited by papers focused on Estrogen and related hormone effects (23 papers), Hormonal and reproductive studies (20 papers) and Growth Hormone and Insulin-like Growth Factors (16 papers). M.F. El Etreby collaborates with scholars based in Germany, United States and Ireland. M.F. El Etreby's co-authors include Y. Nishino, Ursula‐F. Habenicht, Yayun Liang, H. Michna, Martin R. Schneider, Ronald W. Lewis, Klaus-Jürgen Gräf, U.‐F. Habenicht, David Henderson and P. Günzel and has published in prestigious journals such as The Journal of Urology, Pharmacology & Therapeutics and Journal of Investigative Dermatology.

In The Last Decade

M.F. El Etreby

71 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. El Etreby Germany 24 523 468 366 266 215 75 1.3k
Claude Trudel Canada 22 438 0.8× 764 1.6× 499 1.4× 808 3.0× 134 0.6× 35 2.0k
A.O. Brinkmann Netherlands 22 635 1.2× 826 1.8× 904 2.5× 570 2.1× 219 1.0× 32 1.9k
Bruno Barenton France 18 227 0.4× 420 0.9× 439 1.2× 44 0.2× 140 0.7× 46 970
N. Deshpande United Kingdom 15 223 0.4× 210 0.4× 333 0.9× 200 0.8× 57 0.3× 66 930
Robert A. Huseby United States 20 353 0.7× 309 0.7× 364 1.0× 66 0.2× 258 1.2× 62 1.2k
Rong Nie United States 15 935 1.8× 300 0.6× 753 2.1× 90 0.3× 993 4.6× 29 1.9k
Dinesh Stanislaus United States 20 210 0.4× 126 0.3× 592 1.6× 27 0.1× 362 1.7× 41 1.2k
Vincenzo Macchia Italy 23 350 0.7× 646 1.4× 895 2.4× 140 0.5× 55 0.3× 76 1.8k
Stephen Palmer United States 23 294 0.6× 114 0.2× 918 2.5× 44 0.2× 544 2.5× 52 1.9k
Christine Mercier-Bodard France 18 467 0.9× 627 1.3× 388 1.1× 57 0.2× 221 1.0× 27 1.3k

Countries citing papers authored by M.F. El Etreby

Since Specialization
Citations

This map shows the geographic impact of M.F. El Etreby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. El Etreby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. El Etreby more than expected).

Fields of papers citing papers by M.F. El Etreby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. El Etreby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. El Etreby. The network helps show where M.F. El Etreby may publish in the future.

Co-authorship network of co-authors of M.F. El Etreby

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. El Etreby. A scholar is included among the top collaborators of M.F. El Etreby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. El Etreby. M.F. El Etreby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridhar, Supriya, et al.. (2001). Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.. PubMed. 61(19). 7179–83. 20 indexed citations
2.
Etreby, M.F. El, Yayun Liang, Robert W. Wrenn, & Patricia V. Schoenlein. (1998). Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells. Breast Cancer Research and Treatment. 51(2). 149–168. 52 indexed citations
3.
Habenicht, U.‐F., U. Tunn, Th. Senge, et al.. (1993). Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 44(4-6). 557–563. 24 indexed citations
4.
Etreby, M.F. El. (1993). Atamestane: An aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review. The Journal of Steroid Biochemistry and Molecular Biology. 44(4-6). 565–572. 12 indexed citations
5.
Michna, H., et al.. (1991). A bioassay for the evaluation of antiproliferative potencies of progesterone antagonists. The Journal of Steroid Biochemistry and Molecular Biology. 38(3). 359–365. 20 indexed citations
6.
Habenicht, Ursula‐F. & M.F. El Etreby. (1991). Rationale for Using Aromatase Inhibitors to Manage Benign Prostatic Hyperplasia Experimental Studies. Journal of Andrology. 12(6). 395–402. 17 indexed citations
7.
Michna, H., Martin R. Schneider, Y. Nishino, & M.F. El Etreby. (1989). Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studies. Breast Cancer Research and Treatment. 14(3). 275–288. 61 indexed citations
8.
Nickisch, Klaus, et al.. (1989). Effects of Topically Applied Antiandrogenic Compounds on Sebaceous Glands of Hamster Ears and Flank Organs.. Journal of Investigative Dermatology. 92(5). 769–773. 24 indexed citations
9.
Schneider, Martin R., H. Michna, Y. Nishino, & M.F. El Etreby. (1989). Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat. European Journal of Cancer and Clinical Oncology. 25(4). 691–701. 54 indexed citations
10.
Habenicht, Ursula‐F. & M.F. El Etreby. (1988). The periurethral zone of the prostate of the cynomolgus monkey is the most sensitive prostate part for an estrogenic stimulus. The Prostate. 13(4). 305–316. 43 indexed citations
11.
12.
13.
Henderson, David, U.‐F. Habenicht, Y. Nishino, & M.F. El Etreby. (1987). Estrogens and benign prostatic hyperplasia: The basis for aromatase inhibitor therapy. Steroids. 50(1-3). 219–233. 31 indexed citations
14.
Henderson, David, et al.. (1985). 21 Aromatase inhibitors and prostatic hyperplasia. Journal of Steroid Biochemistry. 23. 13–13. 1 indexed citations
15.
Etreby, M.F. El, R. Müller‐Peddinghaus, Akhil Bhargava, & G. Trautwein. (1980). Functional Morphology of Spontaneous Hyperplastic and Neoplastic Lesions in the Canine Pituitary Gland. Veterinary Pathology. 17(2). 109–122. 12 indexed citations
16.
Müller‐Peddinghaus, R., et al.. (1980). Hypophysarer Zwergwuchs beim Deutschen Schäferhund [Pituitary Dwarfism in a German Shepherd Dog—author's trans]. Veterinary Pathology. 17(4). 406–421. 10 indexed citations
17.
Etreby, M.F. El. (1979). Thyroid function in the dog and its possible relationship to mammary tumorigenesis. Pharmacology & Therapeutics. 5(1-3). 403–405. 3 indexed citations
18.
Etreby, M.F. El, Klaus-Jürgen Gräf, S. Beier, et al.. (1979). Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids “short review”. Contraception. 20(3). 237–256. 12 indexed citations
19.
Etreby, M.F. El, et al.. (1974). SEX HORMONES – EFFECTS ON PROLACTIN CELLS IN THE RAT, DOG, MONKEY AND MAN. European Journal of Endocrinology. 77(3_Supplb). S3–S15. 22 indexed citations
20.
Etreby, M.F. El, et al.. (1970). Experimental Ovine Mastitis; A Pathologic Study. Pathologia veterinaria. 7(3). 246–264. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claude Trudel Breakdown of academic impact, for papers by A.O. Brinkmann Breakdown of academic impact, for papers by Bruno Barenton Breakdown of academic impact, for papers by N. Deshpande Breakdown of academic impact, for papers by Robert A. Huseby Breakdown of academic impact, for papers by Rong Nie Breakdown of academic impact, for papers by Dinesh Stanislaus Breakdown of academic impact, for papers by Vincenzo Macchia Breakdown of academic impact, for papers by Stephen Palmer Breakdown of academic impact, for papers by Christine Mercier-Bodard
Rankless by CCL
2026